Entero Therapeutics, Inc.
ENTO
$1.92
$0.021.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -92.42% | -63.67% | -55.43% | -44.63% | -80.70% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.35% | 60.98% | -52.44% | -44.90% | -86.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Current Assets | -0.17% | -0.02% | -0.43% | -0.65% | 1,026.66% |
|
|
|||||
| Total Current Assets | -0.17% | -0.02% | -0.43% | -0.65% | 1,026.66% |
| Net Property, Plant & Equipment | -- | -- | -12.19% | -11.47% | -21.28% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -91.60% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -91.60% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -53.17% | -20.03% | 181.05% | -99.92% |
| Total Assets | -0.17% | -0.24% | -0.48% | -0.54% | -5.32% |
|
|
|||||
| Total Accounts Payable | 15.74% | -3.69% | 33.60% | 9.98% | 0.88% |
| Total Accrued Expenses | 36.69% | 20.60% | 14.96% | -87.97% | -28.65% |
| Short-term Debt | 0.00% | -- | -- | -- | -54.08% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 66.38% | 2.52% | 2.71% | 8.71% |
| Total Finance Division Other Current Liabilities | 1.52% | 2.05% | 84.06% | 16.68% | 869.96% |
| Total Other Current Liabilities | 1.52% | 2.05% | 84.06% | 16.68% | 869.96% |
| Total Current Liabilities | 3.26% | 4.33% | 75.56% | 1.99% | 149.21% |
|
|
|||||
| Total Current Liabilities | 3.26% | 4.33% | 75.56% | 1.99% | 149.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 0.00% | -- | -- | -- | -54.08% |
| Capital Leases | -- | -- | -26.43% | -20.59% | -20.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.26% | 4.11% | 75.04% | 1.84% | 16.70% |
|
|
|||||
| Common Stock & APIC | -0.04% | -0.04% | 0.00% | 0.93% | 0.90% |
| Retained Earnings | -0.49% | -0.62% | -6.44% | -1.38% | -4.93% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -20.71% | -34.59% | -146.32% | -8.24% | -43.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -20.71% | -34.59% | -146.32% | -8.24% | -43.64% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.91% | -2.32% | -17.48% | -1.06% | -9.07% |
|
|
|||||